推薦產品
形狀
liquid
包裝
pkg of 50 mL
製造商／商標名
Chemicon®
IHC Select
技術
immunohistochemistry: suitable (paraffin)
檢測方法
colorimetric
運輸包裝
wet ice
應用
Prediluted for use in Immunohistochemical staining procedures. For example:
Blocking Reagent
Primary Antibody or Negative Control Reagent
Biotinylated Secondary Antibody
Streptavidin-HRP Conjugate
Chromogen
Counterstain
For best results use this conjugate in conjunction with other IHC Select detection reagents. A complete list of reagents is available at www.chemicon.com.
Blocking Reagent
Primary Antibody or Negative Control Reagent
Biotinylated Secondary Antibody
Streptavidin-HRP Conjugate
Chromogen
Counterstain
For best results use this conjugate in conjunction with other IHC Select detection reagents. A complete list of reagents is available at www.chemicon.com.
外觀
Dropper vial containing Streptavidin conjugated to Horseradish Peroxidase in a ready-to-use format
儲存和穩定性
When stored at 2-8°C, this reagent is stable up to the expiration date printed on the label. Do not freeze or expose to elevated temperatures.
法律資訊
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免責聲明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
訊號詞
Warning
危險分類
Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Erika Terzuoli et al.
Cancers, 11(12) (2019-12-11)
Melanoma and non-small-cell lung carcinoma (NSCLC) cell lines are characterized by an intrinsic population of cancer stem-like cells (CSC), and high expression of detoxifying isozymes, the aldehyde dehydrogenases (ALDHs), regulating the redox state. In this study, using melanoma and NSCLC
Ilianna Zoi et al.
Breast cancer research : BCR, 21(1), 132-132 (2019-12-05)
ERBB-2 is overexpressed in about 20% of breast cancers (BCs), indicating poor prognosis. The receptor activator of nuclear factor-κB (RANK) pathway is implicated in ERBB-2 (+) BC. The purpose of this study was to elucidate the underlying molecular mechanism of
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務